Binding of anti-Trypanosoma natural products from African flora against selected drug targets: a docking study
- 11 January 2017
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 26 (3) , 562-579
Abstract
No abstract availableKeywords
Funding Information
- Alexander von Humboldt-Stiftung
This publication has 56 references indexed in Scilit:
- Computer‐Aided Discovery of Trypanosoma brucei RNA‐Editing Terminal Uridylyl Transferase 2 InhibitorsChemical Biology & Drug Design, 2014
- Antitrypanosomal Lead Discovery: Identification of a Ligand-Efficient Inhibitor of Trypanosoma cruzi CYP51 and Parasite GrowthJournal of Medicinal Chemistry, 2013
- Genetic Engineering of Trypanosoma (Dutonella) vivax and In Vitro Differentiation under Axenic ConditionsPLOS Neglected Tropical Diseases, 2011
- Predictive in silico modeling for hERG channel blockersDrug Discovery Today, 2005
- Toward a Pharmacophore for Drugs Inducing the Long QT Syndrome: Insights from a CoMFA Study of HERG K+ Channel BlockersJournal of Medicinal Chemistry, 2002
- Cheminformatic Models To Predict Binding Affinities to Human Serum AlbuminJournal of Medicinal Chemistry, 2001
- The Protein Data BankNucleic Acids Research, 2000
- What Controls Glycolysis in Bloodstream Form Trypanosoma brucei?Journal of Biological Chemistry, 1999
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991
- Epithelial Transport Of Drugs In Cell Culture. I: A Model For Studying The Passive Diffusion Of Drugs Over Intestinal Absorbtive (Caco-2) CellsJournal of Pharmaceutical Sciences, 1990